TROBALT 100 MG

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

RETIGABINE 100 MG

MAH:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC_code:

N03AX21

pharmaceutical_form:

FILM COATED TABLETS

administration_route:

PER OS

manufactured_by:

GLAXO WELLCOME SA, SPAIN

therapeutic_group:

RETIGABINE

therapeutic_indication:

Trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

authorization_date:

2012-11-01